{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:04:10Z","timestamp":1786118650129,"version":"build-2736575974"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,12]]},"DOI":"10.1097\/01.fjc.0000249891.40714.2a","type":"journal-article","created":{"date-parts":[[2007,1,4]],"date-time":"2007-01-04T16:09:43Z","timestamp":1167926983000},"page":"299-305","source":"Crossref","is-referenced-by-count":19,"title":["Peroxisome Proliferator-Activated Receptor \u03b3 Ligand Pioglitazone Alters Neointimal Composition in a Balloon-Denuded and Radiated Hypercholesterolemic Rabbit"],"prefix":"10.1097","volume":"48","author":[{"given":"Rajbabu","family":"Pakala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Dilcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Baffour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hellinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rufus","family":"Seabron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Joner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Kolodgie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renu","family":"Virmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210208","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1161\/01.RES.0000127122.22685.0A","article-title":"Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.","volume":"94","author":"Marx","year":"2004","journal-title":"Circ Res"},{"key":"R2-6-20210208","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1021\/jm990554g","article-title":"The PPARs: From orphan receptors to drug discovery.","volume":"43","author":"Willson","year":"2000","journal-title":"J Med Chem"},{"key":"R3-6-20210208","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1126\/science.294.5548.1866","article-title":"Nuclear receptors and lipid physiology: Opening the X-files.","volume":"294","author":"Chawla","year":"2001","journal-title":"Science"},{"key":"R4-6-20210208","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1161\/01.ATV.0000015598.86369.04","article-title":"Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis.","volume":"22","author":"Barbier","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R5-6-20210208","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/bbrc.1993.1378","article-title":"PPAR-RXR heterodimer activates a peroxisome proliferator response element upstream of the bifunctional enzyme gene.","volume":"192","author":"Bardot","year":"1993","journal-title":"Biochem Biophys Res Commun"},{"key":"R6-6-20210208","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/34184","article-title":"PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines.","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"},{"key":"R7-6-20210208","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/34178","article-title":"The peroxisome proliferator-activated receptor- is a negative regulator of macrophage activation.","volume":"391","author":"Ricote","year":"1998","journal-title":"Nature"},{"key":"R8-6-20210208","doi-asserted-by":"crossref","first-page":"32048","DOI":"10.1074\/jbc.274.45.32048","article-title":"Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1.","volume":"274","author":"Delerive","year":"1999","journal-title":"J Biol Chem"},{"key":"R9-6-20210208","doi-asserted-by":"crossref","first-page":"7614","DOI":"10.1073\/pnas.95.13.7614","article-title":"Expression of the peroxisome proliferator-activated receptor (PPAR) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein.","volume":"95","author":"Ricote","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"R10-6-20210208","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0002-9440(10)65540-X","article-title":"Macrophages in human atheroma contain PPAR: differentiation-dependent peroxisomal proliferator-activated receptor gamma (PPAR) expression and reduction of MMP-9 activity through PPAR activation in mononuclear phagocytes in vitro.","volume":"153","author":"Marx","year":"1998","journal-title":"Am J Pathol"},{"key":"R11-6-20210208","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/31701","article-title":"Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.","volume":"393","author":"Staels","year":"1998","journal-title":"Nature"},{"key":"R12-6-20210208","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1749-6632.2001.tb03979.x","article-title":"Expression of peroxisome proliferator-activated receptor subtypes in human atherosclerosis.","volume":"947","author":"Sueyoshi","year":"2001","journal-title":"Ann NY Acad Sci"},{"key":"R13-6-20210208","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.4049\/jimmunol.164.3.1364","article-title":"The nuclear receptor PPAR gamma and immunoregulation: PPAR gamma mediates inhibition of helper T cell responses.","volume":"164","author":"Clark","year":"2000","journal-title":"J Immunol"},{"key":"R14-6-20210208","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1262-3636(07)70083-6","article-title":"Clinical interest of PPARs ligands.","volume":"30","author":"Verges","year":"2004","journal-title":"Diabetes Metab"},{"key":"R15-6-20210208","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1161\/01.ATV.19.9.2094","article-title":"Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction.","volume":"19","author":"Jackson","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R16-6-20210208","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/01.CIR.101.3.235","article-title":"Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-gamma activators.","volume":"101","author":"Pasceri","year":"2000","journal-title":"Circulation"},{"key":"R17-6-20210208","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1172\/JCI10052","article-title":"Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma.","volume":"106","author":"Han","year":"2000","journal-title":"J Clin Invest"},{"key":"R18-6-20210208","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/01.RES.0000014225.20727.8F","article-title":"PPAR activators as anti-inflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation associated arteriosclerosis.","volume":"90","author":"Marx","year":"2002","journal-title":"Circ Res"},{"key":"R19-6-20210208","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S1097-2765(01)00164-2","article-title":"A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis.","volume":"7","author":"Chawla","year":"2001","journal-title":"Mol Cell"},{"key":"R20-6-20210208","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/83348","article-title":"PPAR-alpha and PPARgamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway.","volume":"7","author":"Chinetti","year":"2001","journal-title":"Nat Med"},{"key":"R21-6-20210208","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1463-1326.2003.00240.x","article-title":"Rosiglitazone (PPAR-agonist) attenuates atherogenesis with no effect on hyperglycemia in a combined diabetes-atherosclerosis mouse model.","volume":"5","author":"Levi","year":"2003","journal-title":"Diabetes Obes Metab"},{"key":"R22-6-20210208","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1172\/JCI10370","article-title":"Peroxisome proliferator-activated receptor ligands inhibit development of atherosclerosis in LDL receptor-deficient mice.","volume":"106","author":"Li","year":"2000","journal-title":"J Clin Invest"},{"key":"R23-6-20210208","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1172\/JCI18730","article-title":"Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPAR, \/, and .","volume":"114","author":"Li","year":"2004","journal-title":"J Clin Invest"},{"key":"R24-6-20210208","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1161\/01.ATV.21.3.365","article-title":"Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice.","volume":"21","author":"Collins","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R25-6-20210208","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1161\/01.ATV.21.3.372","article-title":"Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL.","volume":"21","author":"Chen","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R26-6-20210208","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1161\/01.CIR.0000092886.52404.50","article-title":"Rosiglitazone reduces the accelerated neointima formation after arterial injury in a mouse injury model of type 2 diabetes.","volume":"108","author":"William","year":"2003","journal-title":"Circulation"},{"key":"R27-6-20210208","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/107424840300800407","article-title":"Differential effects of peroxisome proliferator activator receptor-alpha and gamma ligands on intimal hyperplasia after balloon catheter-induced vascular injury in Zucker rats.","volume":"8","author":"Desouza","year":"2003","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"R28-6-20210208","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.2337\/diacare.27.11.2654","article-title":"Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes.","volume":"27","author":"Choi","year":"2004","journal-title":"Diabetes Care"},{"key":"R29-6-20210208","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1016\/j.ahj.2003.12.006","article-title":"Effect of rosiglitazone on restenosis after coronary stenting in patients with type 2 diabetes.","volume":"147","author":"Osman","year":"2004","journal-title":"Am Heart J"},{"key":"R30-6-20210208","first-page":"139","article-title":"Thiazolidinedione treatment attenuates diffuse neointimal hyperplasia in restenotic lesions after coronary stent implantation in type 2 diabetic patients: an intravascular ultrasound study.","volume":"45","author":"Takagi","year":"2005","journal-title":"J Cardiol"},{"key":"R31-6-20210208","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0735-1097(00)00895-0","article-title":"Troglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with non-insulin dependent diabetes mellitus: a serial intravascular ultrasound study.","volume":"36","author":"Takagi","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"R32-6-20210208","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.1016\/S0002-8703(03)00146-7","article-title":"Pioglitazone reduces neointimal tissue proliferation after coronary stent implantation in patients with type 2 diabetes mellitus: an intravascular ultrasound scanning study.","volume":"146","author":"Takagi","year":"2003","journal-title":"Am Heart J"},{"key":"R33-6-20210208","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1161\/01.ATV.0000124890.40436.77","article-title":"Effect of rosiglitazone on common carotid intima-media thickness progression in coronary artery disease patients without diabetes mellitus.","volume":"24","author":"Sidhu","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R34-6-20210208","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1161\/CIRCULATIONAHA.105.535484","article-title":"Pioglitazone reduces neointima volume after coronary stent implantation: a randomized, placebo-controlled, double-blind trial in nondiabetic patients.","volume":"112","author":"Marx","year":"2005","journal-title":"Circulation"},{"key":"R35-6-20210208","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/S1522-1865(03)00182-3","article-title":"Radiation-induced atherosclerotic plaque progression in a hypercholesterolemic rabbit: a prospective vulnerable plaque model?","volume":"4","author":"Pakala","year":"2003","journal-title":"Cardiovasc Radiat Med"},{"key":"R36-6-20210208","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/01.fjc.0000179436.03502.26","article-title":"Effect of antioxidants on atherosclerotic plaque formation in balloon-denuded and irradiated hypercholesterolemic rabbits.","volume":"46","author":"Leborgne","year":"2005","journal-title":"J Cardiovasc Pharmacol"},{"key":"R37-6-20210208","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/09553009414550041","article-title":"Free radicals in biology: oxidative stress and the effects of ionizing radiation.","volume":"65","author":"Riley","year":"1994","journal-title":"Int J Radiat Biol"},{"key":"R38-6-20210208","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1161\/01.ATV.19.6.1387","article-title":"Ionizing radiation accelerates aortic lesion formation in fat-fed mice via SOD inhibitable processes.","volume":"19","author":"Tribble","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R39-6-20210208","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1006\/bbrc.1995.2841","article-title":"Eselectin gene induction by ionizing radiation is independent of cytokine induction.","volume":"217","author":"Hallahan","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"R40-6-20210208","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/01.ATV.19.3.588","article-title":"Irradiation induces up regulation of CD31 in human endothelial cells.","volume":"19","author":"Quarmby","year":"1999","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R41-6-20210208","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1172\/JCI116778","article-title":"Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells.","volume":"92","author":"Marui","year":"1993","journal-title":"J Clin Invest"},{"key":"R42-6-20210208","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1161\/01.CIR.97.24.2445","article-title":"N-acetyl-cysteine decreases the matrix-degrading capacity of macrophage-derived foam cells: new target for antioxidant therapy?","volume":"97","author":"Galis","year":"1998","journal-title":"Circulation"},{"key":"R43-6-20210208","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1161\/01.CIR.94.5.928","article-title":"Vulnerable plaque. Relation of characteristics to degree of stenosis in human coronary arteries.","volume":"94","author":"Mann","year":"1996","journal-title":"Circulation"},{"key":"R45-6-20210208","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/nm1102-1257","article-title":"Stabilization of atherosclerotic plaques: new mechanisms and clinical targets.","volume":"8","author":"Libby","year":"2002","journal-title":"Nat Med"},{"key":"R46-6-20210208","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1172\/JCI118991","article-title":"Troglitazone inhibits vascular smooth muscle cell growth and intimal hyperplasia.","volume":"98","author":"Law","year":"1996","journal-title":"J Clin Invest"},{"key":"R47-6-20210208","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/meta.2001.19415","article-title":"The ligands\/activators for peroxisome proliferator-activated receptor alpha (PPARalpha) and PPARgamma increase Cu2+,Zn2+-superoxide dismutase and decrease p22phox message expressions in primary endothelial cells.","volume":"50","author":"Inoue","year":"2001","journal-title":"Metabolism"},{"key":"R48-6-20210208","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1161\/01.CIR.0000097003.49585.5E","article-title":"Antioxidative, antinitrative, and vasculoprotective effects of a peroxisome proliferator-activated receptor-gamma agonist in hypercholesterolemia.","volume":"108","author":"Tao","year":"2003","journal-title":"Circulation"},{"key":"R49-6-20210208","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/01.HYP.36.3.430","article-title":"Troglitazone reduces reactive oxygen species generation by leukocytes and lipid peroxidation and improves flow-mediated vasodilatation in obese subjects.","volume":"36","author":"Garg","year":"2000","journal-title":"Hypertension"}],"container-title":["Journal of Cardiovascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00005344-200612000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:22:16Z","timestamp":1786033336000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005344-200612000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12]]},"references-count":48,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.fjc.0000249891.40714.2a","relation":{},"ISSN":["0160-2446"],"issn-type":[{"value":"0160-2446","type":"print"}],"subject":[],"published":{"date-parts":[[2006,12]]}}}